| HR (95% CI) | P for trend | AIC | C index % |
---|
1st (reference) | 2nd | 3rd | 4th | Â | Â | Â |
---|
Insulina |
 Model 1 | 1.00 | 1.15 (0.88–1.50) | 1.48 (1.14–1.92) | 1.85 (1.44–2.37) | <  0.001 | 8920.4 | 71.6 |
 Model 2 | 1.00 | 1.02 (0.78–1.33) | 1.37 (1.05–1.77) | 1.48 (1.15–1.90) | 0.001 | 8572.3 | 79.7 |
 Model 3 | 1.00 | 0.96 (0.73–1.25) | 1.27 (0.98–1.66) | 1.31 (1.01–1.69) | 0.015 | 8556.7 | 80.1 |
HOMA-IRb |
 Model 1 | 1.00 | 0.99 (0.76–1.28) | 1.15 (0.89–1.49) | 1.65 (1.30–2.10) | <  0.001 | 8925.9 | 71.4 |
 Model 2 | 1.00 | 0.86 (0.66–1.12) | 1.08 (0.83–1.40) | 1.34 (1.05–1.71) | 0.002 | 8572.0 | 79.6 |
 Model 3 | 1.00 | 0.81 (0.63–1.06) | 1.00 (0.77–1.30) | 1.18 (0.92–1.52) | 0.016 | 8555.6 | 80.1 |
IGRc |
 Model 1 | 1.00 | 1.30 (1.00–1.69) | 1.62 (1.25–2.09) | 1.98 (1.54–2.54) | <  0.001 | 8925.0 | 71.6 |
 Model 2 | 1.00 | 1.28 (0.99–1.67) | 1.52 (1.17–1.97) | 1.68 (1.31–2.17) | <  0.001 | 8568.1 | 79.8 |
 Model 3 | 1.00 | 1.21 (0.93–1.58) | 1.40 (1.08–1.82) | 1.53 (1.18–1.98) | 0.008 | 8553.8 | 80.2 |
- HOMA-IR homeostasis model assessment of insulin resistance, IGR insulin-glucose ratio, HR hazard ratio, CI confidence interval, AIC Akaike’s information criteria, CVD cardiovascular disease, SBP systolic blood pressure, DBP diastolic blood pressure, BMI body mass index, FPG fasting plasma glucose, TC total cholesterol, TG triglycerides, HDL-C high density lipoprotein cholesterol, eGFR estimated glomerular filtration rate
- aModel 1: adjusted for age, sex, and baseline insulin; Model 2: model 1 + smoking, physical activity, marital status, history of CVD, education level, and baseline levels of SBP, DBP, BMI, FPG, TC, TG, HDL-C, and eGFR; Model 3: model 2 + BMI changes
- bModel 1: adjusted for age, sex, and baseline HOMA-IR; Model 2: model 1 + smoking, physical activity, marital status, history of CVD, education level, and baseline levels of SBP, DBP, BMI, TC, TG, HDL-C, and eGFR; Model 3: model 2 + BMI changes
- cModel 1: adjusted for age, sex, and baseline IGR; Model 2: model 1 + smoking, physical activity, marital status, history of CVD, education level, and baseline levels of SBP, DBP, BMI, TC, TG, HDL-C, and eGFR; Model 3: model 2 + BMI changes